Business Wire

SpaceRISE Signs Concession Contract to Deliver Europe’s IRIS 2 Connectivity Network

Share

SES S.A. announces that the SpaceRISE consortium, led by SES, has signed the Concession Contract with the European Commission to design, deliver, and operate the innovative, multi-orbit IRIS2 sovereign connectivity system for a period of 12 years, with the network expected to provide services from the beginning of 2030.

Infrastructure for Resilience, Interconnectivity and Security by Satellite (IRIS2) will be European Union's (EU) preferred and trusted network to provide reliable, secure, and cost-effective communication solutions for governmental institutions, commercial organisations, and European citizens.

SES’s contribution to IRIS2 will be to develop, procure, and operate 18 new MEO satellites providing 100% pole-to-pole coverage with carrier-grade connectivity solutions. SES will have rights to commercialise the MEO capacity and part of the LEO capacity of the IRIS2 system. The compelling combination of high throughput data rates, low latency, service flexibility, and managed solutions will cater to EU’s sophisticated requirements, as well as allied nations and SES’s customers around the world.

With deployment of SES’s O3b mPOWER completed in 2027 and subsequent commercial ramp up, the delivery of IRIS2 is well timed to provide next-generation MEO capabilities to serve expanding customer demand for SES’s high performance connectivity solutions, underpinning profitable growth into the next decade. The IRIS2 satellites will form the foundation for SES's next-generation MEO capabilities.

Adel Al-Saleh, Chief Executive Officer of SES, commented, “We are delighted to secure this important contract as the European Commission’s trusted partner for this flagship project to realise the ambition of secure, sovereign multi-orbit-based network for EU’s strategic communications autonomy. IRIS2 will bring a new level of connectivity for the EU and its citizens in a public private partnership structure which aligns all interests and derisks the development phase with upfront public investment. IRIS2 will be Europe’s network of choice with the EU and Member States being the constellation’s anchor customers.

IRIS2 enables the profitable expansion of our differentiated MEO architecture into the next decade, while giving us access to LEO with owners' economics, to keep pace with the rapidly growing customer demand in our target segments where we have a strong right to win, record of delivering value for our customers, and history of growth execution. The contract terms we have agreed demonstrate our commitment to disciplined investment, delivering required rate of return, maintaining investment grade balance sheet metrics, and returning cash to our shareholders.”

The Internal Rate Return (IRR) of the contract is expected to exceed 10% and is underpinned by a strong commercial value proposition and built-in protection mechanisms. The MEO offering, complemented by access to LEO capacity, will serve a range of government and commercial requirements including fixed government connectivity; intelligence, surveillance, and reconnaissance; navy and air force needs; mobile backhaul and trunking; enterprise and cloud applications; global inflight connectivity; and connecting cruise ships around the world.

The initial phases of IRIS2 will benefit from upfront public funding with limited need for private financing in the early years of design and procurement. In total, SES will contribute approximately 50% of the MEO cost while having the benefit of commercialising over 90% of the MEO capacity and part of the LEO capacity.

The EU and Member States will be the anchor customers to the IRIS2 constellation, while also attracting allied nations across the world, underpinning revenue generation which is expected to cumulatively be around €6 billion over the 12 years. Starting in 2025, SES expects to generate incremental revenue and EBITDA for works related to the design and procurement phases. The Contract also provides for the possibility to add hosted payloads for commercial services, adding to the value proposition towards customers.

The contract grants protections to support SES’s IRR including, but not limited to, i) a rendezvous point in 12 months’ time to validate the project cost, technical requirements, and delivery timetable, whereby any party can exit in the event of excess expected cost, not meeting technical requirements, and/or delays to the in-service date; ii) mechanism to seek renegotiation to protect the IRR for qualifying reasons, such as delay in start of service; iii) certain protections from annual cost overruns; and iv) the Commission will cover any extra cost resulting from launch failures up to in-orbit validation.

Participation in IRIS2 is fully consistent with the principles of SES’s financial policy. SES maintains its prior expectation to have an Adjusted Net Debt to Adjusted EBITDA ratio of below 3 times within 12-18 months after closing the Intelsat acquisition, which is on track to complete during H2 2025. SES’s commitment to a stable to progressive dividend is also reaffirmed with an annual base dividend of at least €0.50 per A-share. SES intends to increase the annual dividend as soon as the Adjusted Net Debt to Adjusted EBITDA ratio is reduced to below 3 times which is expected by 2027 as noted above.

The IRIS2 contract will be incremental to SES’s current investment outlook (average of around €350 million per year on a standalone basis and €600-650 million per year pro forma for the Intelsat acquisition over 2025-2030), revenue, and profit plans. The capital expenditure (CapEx) for IRIS2 of up to €1.8 billion will start ramping from 2027 and have an average annual spend of around €400 million over 2027-2030.

With the Intelsat acquisition, normalised Adjusted Free Cash Flow (pre-IRIS2) is expected to ramp to over €1 billion by 2027/2028(1) driven by revenue and Adjusted EBITDA growth and execution of synergies (approximately 70% of the expected total annual rate of €370 million will be delivered by the end of Year 3). This level of cash generation will more than support the incremental CapEx for IRIS2 while retaining financial flexibility to increase shareholder returns and consider further balance sheet strengthening.

Click below links for other releases issued by the European Institutions:

European Commission
European Space Agency

Follow us on:

LinkedIn | Facebook | YouTube | Twitter | Instagram

Read our Blogs
Visit the Media Gallery >

About SES

SES has a bold vision to deliver amazing experiences everywhere on Earth by distributing the highest quality video content and providing seamless data connectivity services around the world. As a provider of global content and connectivity solutions, SES owns and operates a geosynchronous orbit fleet and medium earth orbit (GEO-MEO) constellation of satellites, offering a combination of global coverage and high performance services. By using its intelligent, cloud-enabled network, SES delivers high-quality connectivity solutions anywhere on land, at sea or in the air, and is a trusted partner to telecommunications companies, mobile network operators, governments, connectivity and cloud service providers, broadcasters, video platform operators and content owners around the world. The company is headquartered in Luxembourg and listed on Paris and Luxembourg stock exchanges (Ticker: SESG). Further information is available at: www.ses.com.

1) Financial outlook assumes nominal satellite health and launch schedule

View source version on businesswire.com: https://www.businesswire.com/news/home/20241216108829/en/

Contacts

Richard Whiteing
Investor Relations
Tel. +352 710 725 261
richard.whiteing@ses.com

Suzanne Ong
Communications
Tel. +352 710 725 500
suzanne.ong@ses.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

A-CAP Announces Successful Divestiture of Standard de Liège SA and Immobilière du Standard de Liège SRL6.6.2025 23:32:00 EEST | Press release

Advantage Capital Holdings, LLC (“A-CAP” or “The Company”), a New York-based insurance and financial services company with over $12 billion in assets, today announced the successful divestiture of Standard de Liège SA (“Standard Liège” or the “Club”), one of Belgium's most historic soccer clubs, and Immobilière du Standard de Liège SRL, the corporate entity that owns the Club's stadium, Maurice Dufrasne Stadium, to a consortium of buyers led by Standard Liège Chief Executive Officer Giacomo Angelini. This transaction marks the end of 777 Partners’ legacy involvement with the Club and sets the stage for the Club’s future growth and success, both on and off the field. Benefits of the transaction include: Increased stability across the Club’s shareholder base, which clears the path for future investments, Operational clarity, establishing a unified direction that will allow both players and management to fully concentrate on on-field performance, ensuring that collective focus remains on

Populous Acquires Fentress Architects, Expanding Global Aviation Portfolio6.6.2025 21:00:00 EEST | Press release

Populous, the world-renowned design firm specializing in sport and entertainment venues, today announced the acquisition of Denver-based Fentress Architects, a global leader in iconic aviation projects and prominent public buildings, including convention centers, museums and government facilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606849000/en/ Los Angeles International Airport. Designed by Fentress Architects. This strategic acquisition unites two of the most respected names in architecture, combining Populous’ unparalleled expertise in designing memorable experiences with Fentress’ award-winning portfolio of aviation, civic and cultural landmarks. The acquisition significantly broadens the scope and scale of services that Populous can offer clients across the globe. Bruce Miller, Populous Global Chair and CEO, commented: “We are committed to expanding the breadth of our practice. Fentress Architects has lon

Vertex Presents New Data on Benefits of ALYFTREK ® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 19:00:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conference, the Company presented data from a pooled analysis across CFTR modulators, including ALYFTREK, which demonstrate that reduction in sweat chloride (SwCl), and therefore greater restoration of CFTR function, is associated with improved outcomes in people with cystic fibrosis (CF). For all clinical outcomes in the study, SwCl levels below 60 mmol/L were associated with greater benefit

IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10 th Anniversary Year of NAHYCO ® Technology6.6.2025 17:00:00 EEST | Press release

IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the latest innovations and cutting-edge advancements in aesthetic procedures and treatments, staying at the forefront of this dynamic field. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250603094257/en/ IBSA’s stand at IMCAS Asia 2025 As part of the congress, IBSA Derma will host a scientific symposium titled “The Future of Tissue Regeneration with NAHYCO® Technology. Feeling and Seeing the Results with Profhilo® Line” scheduled for Saturday, June 7, from 3:00 to 4:00 pm ICT in Room 1 - Level 2. Internationally renowned speakers – Dr. Lam Bee Lan and Prof. Ofir Artzi – will lead

HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors6.6.2025 15:00:00 EEST | Press release

HistoSonics, Inc., the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the completion of patient enrollment in its pivotal #HOPE4KIDNEY trial. This prospective, multi-center, single-arm trial is designed to evaluate the safety and effectiveness of the Edison System in destroying kidney tissue by treating primary solid kidney tumors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606659747/en/ Edison Histotripsy System Procedure for Kidney Tumor Animation The trial enrolled patients with a single, non-metastatic solid kidney mass ≤3 cm, confirmed by imaging and biopsy. Subjects will be followed for five years post-procedure, with evaluations at multiple time points, including 14-day, 30-day, 90-day, 180-day, and annual assessments. The Edison System remains in investigational use for kidney applications and is not yet FDA-approved for this indication. Data from the #H

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye